NEW YORK, Jan 4 (Reuters) - A U.S. federal judge has denied motions to certify classes of users of osteoporosis drug Fosamax who wanted Merck & Co to set up a program to monitor them for an ailment ...

NEW YORK — Lawyers for Fosamax users who believe their jaws were damaged by the osteoporosis drug on Friday asked a federal judge to order Merck & Co. to provide a dental monitoring program for the ...

LONDON, ONTARIO--(Marketwired - Apr 10, 2015) - A settlement has been reached which, if approved by the courts and fully implemented, will resolve Fosamax and Fosavance claims across Canada. Class and ...

A Canadian consumer group is considering filing a class-action complaint against Merck Frosst for failing to disclose side effects connected with the bisphosphonate drug Fosamax, according to an ...

MONTREAL – A non-profit Montreal-based consumer group wants to launch a class-action suit against pharmaceutical giant Merck Frosst for failing to disclose side effects connected with Fosamax, an ...

A total of 19 chronic SCI patients were evaluated, divided into a control group and an experimental group. Control group patients received 1000 mg of calcium daily, and experimental group patients ...